Harmony Biosciences Holdings, Inc. (HRMY) Institutional Ownership & Insider Trading

327 institutions reported holding Harmony Biosciences Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HRMYHarmony Biosciences Holdings, Inc.Follow HRMY — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 2.1B
P/E TTM: 11.7
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

327 institutions held 93.0% of the shares. Across filers that reported both quarters, shares held changed -3.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	327	54	-3.5%	127	42	100	27
Mar 26	308	56	+12.8%	125	33	87	43
Dec 25	315	50	+5.0%	106	43	99	23
Sep 25	289	47	-7.1%	106	35	76	22
Jun 25	275	51	+2.1%	114	36	63	27
Mar 25	264	50	-4.1%	88	33	79	14
Dec 24	244	53	+4.0%	120	26	43	21
Sep 24	230	50	-2.1%	67	30	79	22

Harmony Biosciences Holdings, Inc. — questions

Who owns Harmony Biosciences Holdings, Inc. stock?: 327 institutions reported Harmony Biosciences Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (12.2%), FMR LLC (6.1%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.0%).
Are Harmony Biosciences Holdings, Inc. insiders buying or selling?: 13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Harmony Biosciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.